Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s465. https://doi.org/10.25251/skin.8.supp.465